Rallybio CorporationRLYBNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank67
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-29.81M
↑ 25% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-40.00M
Historical baseline
PeriodValueYoY Change
2025$-29.81M+39.5%
2024$-49.28M+18.2%
2023$-60.28M-5.1%
2022$-57.34M-25.0%
2021$-45.87M-106.8%
2020$-22.18M-45.8%
2019$-15.21M-